Teleflex (NYSE:TFX) reported second-quarter revenue and adjusted earnings above its expectations, supported by strong growth in its Vascular and Surgical businesses, while slower-than-anticipated ...

Teleflex Inc. Annual cash flow by MarketWatch. View TFX net cash flow, operating cash flow, operating expenses and cash dividends.

Teleflex quarterly update covers Russell 1000 healthcare operations, medical device products, hospital technologies, global ...

Teleflex (TFX) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $3.73 per share a year ago. These figures are ...

Explore Teleflex FDA-approved plasma platform, healthcare operations, trauma care technologies, product developments, and S&P ...

Medical technology company Teleflex (NYSE:TFX) reported Q2 CY2026 results , with sales up 28.9% year on year to $570.3 ...

Combining leading in-house expertise with platform-enhancing investments to accelerate advances in engineering, innovation and manufacturing ...

Medical technology company Teleflex (NYSE:TFX) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with ...

Teleflex Incorporated has announced a contract with Vizient, Inc. for the supply of its Central Venous Access Catheters and Arterial Catheters, effective January 1, 2025. Vizient, the largest provider ...

Teleflex may be enjoying improved profits and sales. But it will still lay off workers and close plants as it restructures in the face of what top executive Benson F. Smith describes as "continuing ...